HEMP — Hempalta Income Statement
0.000.00%
Last trade - 00:00- CA$1.42m
- CA$1.85m
- CA$0.00m
Annual income statement for Hempalta, fiscal year end - September 30th, CAD millions except per share, conversion factor applied.
2022 September 30th | 2023 September 30th | 2024 September 30th | 2025 September 30th | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 0 | 0 | 0.54 | 0.003 |
| Cost of Revenue | ||||
| Gross Profit | — | — | -0.345 | 0.002 |
| Selling / General / Administrative Expenses | ||||
| Depreciation and Amortization | ||||
| Unusual Expense / Income | ||||
| Total Operating Expenses | 0.45 | 0.067 | 5.32 | 1.14 |
| Operating Profit | -0.45 | -0.067 | -4.78 | -1.13 |
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | -0.443 | 0.058 | -6.5 | -1.13 |
| Net Income After Taxes | -0.443 | 0.058 | -6.5 | -1.13 |
| Minority Interest | ||||
| Net Income Before Extraordinary Items | ||||
| Extraordinary Items | ||||
| Net Income | -0.443 | 0.058 | -6.44 | -4.81 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -0.443 | 0.058 | -6.44 | -4.81 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -0.022 | 0.002 | -0.062 | -0.012 |